DFL24498 Clinical Trials (2026): 2 Studies for Atopic Keratoconjunctivitis & Dry Eye Disease (DED)
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
2 DFL24498 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 2 indications (including Atopic Keratoconjunctivitis & Dry Eye Disease (DED)) and 555 total planned enrollment. 1 Phase 3 DFL24498 trial and 1 Phase 2 are listed. 2 DFL24498 clinical trials are actively recruiting at 8 U.S. sites across 7 states. Most recent activity: NCT07395232 (May 2027).
Where to Participate: All DFL24498 Trial Sites in the U.S. (8 sites across 7 states)
Every actively recruiting DFL24498trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| FL | Bowden Eye Associates - Southside Location | Jacksonville32256 | NCT07395232 | Map |
| FL | University of Miami, Miller School of Medicine, Bascom Palmer Eye Institute | Miami33136 | NCT07395232 | Map |
| GA | Clayton Eye Clinical Research | Morrow30260 | NCT07395232 | Map |
| MO | Ophthalmology Associates | St Louis63131 | NCT07395232 | Map |
| NY | NYU Langone Health - Eye Center | New York10017 | NCT07395232 | Map |
| NC | Duke Eye Center - Ophthalmology | Durham27710 | NCT07395232 | Map |
| TN | Total Eye Care, PA | Memphis38119 | NCT07395232 | Map |
| TX | Baylor University Jamail Specialty Care Center- Alkek Eye Center- Ophthalmology | Houston77030 | NCT07395232 | Map |
DFL24498 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | not yet recruiting | Total |
|---|---|---|---|
| P2 | 1 | 1 | |
| P3 | 1 | 1 |
Recruiting DFL24498 clinical trials (2)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07395232 | An Efficacy and Safety Study of DFL24498 in the Treatment of AKC | P3 | Atopic Keratoconjunctivitis | 138 | Dec 2025 |
| NCT07503886 | An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease | P2 | Dry Eye Disease (DED) | 417 | May 2026 |
DFL24498 clinical trials by indication
Dry Eye Disease (DED) (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07503886 | — | P2 | not yet recruiting | An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease |
Atopic Keratoconjunctivitis (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07395232 | — | P3 | recruiting | An Efficacy and Safety Study of DFL24498 in the Treatment of AKC |
All DFL24498 trials (2)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07395232 | An Efficacy and Safety Study of DFL24498 in the Treatment of AKC | P3 | recruiting | 138 | Dompé Farmaceutici S.p.A | Dec 2025 | |
| NCT07503886 | An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease | P2 | not yet recruiting | 417 | Dompé Farmaceutici S.p.A | May 2026 |
DFL24498 clinical trials: frequently asked questions
- How many DFL24498 clinical trials are there?
- 2 DFL24498 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are DFL24498 clinical trials recruiting in 2026?
- Yes — 1 DFL24498 trial is actively recruiting in 2026, with 8 U.S. sites across 7 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is DFL24498 being studied for?
- DFL24498 is being studied for Atopic Keratoconjunctivitis, Dry Eye Disease (DED). The trials are grouped by indication on this page.
- What phase is DFL24498 in?
- DFL24498 clinical trials span 1 Phase 3, 1 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors DFL24498 clinical trials?
- The lead sponsor across the most DFL24498 trials is Dompé Farmaceutici S.p.A. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming DFL24498as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: